TCG Advisory Services LLC Makes New Investment in DaVita Inc. (NYSE:DVA)

TCG Advisory Services LLC bought a new position in shares of DaVita Inc. (NYSE:DVA) in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 3,500 shares of the company’s stock, valued at approximately $367,000.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Hanseatic Management Services Inc. acquired a new position in shares of DaVita during the third quarter worth about $36,000. GAMMA Investing LLC bought a new position in DaVita in the fourth quarter valued at approximately $60,000. Tacita Capital Inc bought a new position in DaVita in the third quarter valued at approximately $118,000. Federated Hermes Inc. boosted its stake in shares of DaVita by 1,284.4% during the 3rd quarter. Federated Hermes Inc. now owns 1,246 shares of the company’s stock worth $118,000 after acquiring an additional 1,156 shares during the period. Finally, CENTRAL TRUST Co boosted its stake in shares of DaVita by 93.3% during the 3rd quarter. CENTRAL TRUST Co now owns 1,448 shares of the company’s stock worth $137,000 after acquiring an additional 699 shares during the period. Institutional investors own 90.12% of the company’s stock.

DaVita Trading Up 1.6 %

Shares of NYSE DVA traded up $2.15 during trading on Monday, reaching $136.60. The company had a trading volume of 230,122 shares, compared to its average volume of 831,713. The stock has a market cap of $11.98 billion, a P/E ratio of 15.28, a PEG ratio of 1.17 and a beta of 1.04. The company has a quick ratio of 1.37, a current ratio of 1.43 and a debt-to-equity ratio of 7.95. The company’s fifty day moving average price is $133.71 and its 200-day moving average price is $113.08. DaVita Inc. has a 12 month low of $71.51 and a 12 month high of $145.04.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Thursday, May 2nd. The company reported $2.38 earnings per share for the quarter, topping analysts’ consensus estimates of $1.95 by $0.43. DaVita had a return on equity of 68.52% and a net margin of 6.61%. The business had revenue of $3.07 billion for the quarter, compared to the consensus estimate of $3.03 billion. During the same period in the prior year, the business earned $1.58 EPS. The firm’s revenue for the quarter was up 6.9% on a year-over-year basis. As a group, research analysts expect that DaVita Inc. will post 9.49 earnings per share for the current year.

Wall Street Analyst Weigh In

DVA has been the subject of several research analyst reports. TheStreet upgraded DaVita from a “c+” rating to a “b-” rating in a research note on Wednesday, February 7th. Barclays assumed coverage on DaVita in a report on Wednesday, March 6th. They issued an “equal weight” rating and a $133.00 price objective for the company. StockNews.com upgraded DaVita from a “buy” rating to a “strong-buy” rating in a research note on Thursday, April 25th. Truist Financial lifted their price target on DaVita from $130.00 to $135.00 and gave the company a “hold” rating in a research note on Tuesday, February 20th. Finally, UBS Group lifted their price target on DaVita from $113.00 to $134.00 and gave the company a “buy” rating in a research note on Wednesday, February 14th. Two analysts have rated the stock with a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $118.50.

Insider Transactions at DaVita

In other news, insider Kathleen Alyce Waters sold 11,285 shares of the company’s stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $120.73, for a total value of $1,362,438.05. Following the completion of the transaction, the insider now directly owns 81,297 shares of the company’s stock, valued at $9,814,986.81. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other DaVita news, insider James O. Hearty sold 26,164 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $119.64, for a total transaction of $3,130,260.96. Following the sale, the insider now owns 20,264 shares in the company, valued at $2,424,384.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Kathleen Alyce Waters sold 11,285 shares of the firm’s stock in a transaction dated Wednesday, February 21st. The shares were sold at an average price of $120.73, for a total value of $1,362,438.05. Following the sale, the insider now owns 81,297 shares in the company, valued at approximately $9,814,986.81. The disclosure for this sale can be found here. Insiders sold a total of 134,540 shares of company stock valued at $16,551,071 over the last ninety days. 1.40% of the stock is currently owned by insiders.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.